The general objective of this project is to promote the physical and emotional health of adolescents suffering from chronic disease T1DM, enhancing the development of socio-emotional competencies through a psychological intervention carried out using a technological platform that incorporates artificial intelligence and Ecological Momentary Assessment

The specific objectives are:

1. Identify the variables being studied and the appropriate assessment methods
2. Design of assessment and intervention activities associated with the technological platform
3. Graphic and design patterns for MApp (mobile application) and development of the contents of the MApp áreas
4. Validation of the activities corresponding to each area of the technological platform
5. Adaptation of the results in the contents of the areas of the MApp
6. Development of the Web Server Platform (WSP)
7. Incorporation into the technological platform and incorporation of the mobile device (emoTICare programme)
8. Application of emoTICare in the age groups indicated in the different countries
9. Analysis of the benefits from the implementation of the programme
10. Identification and incorporation of improvements in the emoTICare technological platform
11. Dissemination of the validated application for the improvement of emotional competencies and the promotion of well-being and planning of future lines

The target population consists of adolescents between 12 and 16 years of age with Type 1 Diabetes Mellitus, the most common chronic endocrinological disease in this age group.

Participation will be voluntary.

Inclusion criteria will be:

1. adolescents between 12 and 16 years old diagnosed with T1DM for at least 6 months,
2. without a psychological diagnosis prior to the start of their participation in the study;
3. given that participants are under 18 years of age, informed consent will be requested from parents or legal guardians, ensuring their agreement.

Participants will be randomly assigned to the control and experimental groups and will mainly come from paediatric endocrinology units of leading hospitals in the Valencian Community (such as the Hospital Clínico Universitario or the Consorcio Hospital General Universitario of Valencia).

This study will be focused on the implementation of an intervention programme through a technological platform with a quasi-experimental and longitudinal design.

In the first phase, the application will be designed, and subsequently, the intervention programme will be implemented in a pilot sample of patients to test the functioning of the platform’s beta version. This will allow the detection of possible errors in the application and develop a definitive version that all patients can use.

After developing the new definitive version of the platform, including the improvements established from the pilot sample results, an evaluation session will be conducted with the patients, which will include the measurement of the psychological and medical variables under study . Three months after this evaluation, a new evaluation of these variables will be carried out. After completion of the intervention programme, a new series of diagnostic tests will be performed (within an estimated period no later than 15 days from the treatment) to evaluate the post-treatment changes.